Lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome

Bilateral ureteral obstruction after open ureteral reimplantation in a 3-year-old patient with Williams Beuren syndrome

Vesicoureteral reflux (VUR) is a common urological problem in the pediatric population and can be corrected by ureteral reimplantation in severe or persistent cases. This procedure is generally well tolerated, although complications, including ureteral obstruction, may occur in the postoperative period. We present a rare case of a 3-year-old with Williams Beuren syndrome who underwent bilateral ureteral reimplantation for VUR and subsequently developed bilateral ureteral obstruction with acute renal failure requiring nephrostomy tube placement within 48 hours of surgery.

Multiple bladder diverticula with Williams-Beuren syndrome: a case report

Williams-Beuren syndrome (WBS) is an autosomal dominant disorder caused by a gene deletion on chromosome 7q11.23. Patients with WBS usually show a group of features such as developmental delay, cardiovascular anomalies, mental retardation, and characteristic facial appearance. It occurs in 1:7,500 live births and affects males and females equally. Recent studies showed that lower urinary tract symptoms were also frequent in WBS patients. However, there is extremely rare study report non-monosymptomatic nocturnal enuresis as the main manifestation of Williams syndrome in children. We reported a child with non-monosymptomatic nocturnal enuresis and multiple bladder diverticula as the main implications of Williams syndrome. A 7.6-year-old girl was admitted to our hospital due to frequent micturition, urgency, and nocturnal enuresis for 4 years, and B ultrasound of urinary system revealed multiple bladder diverticula. The patient was found to have 7q11.23 deletion that involves the elastin gene for WBS. Multiple bladder diverticula in WBS patients can lead to many lower urinary tract symptoms. The treatment for the lower urinary tract symptoms in WBS patients with multiple bladder diverticula is lacking. Lower urinary tract symptoms should be considered as a significant indicator of the clinical diagnosis of WBS and have a significant negative impact on patient's quality of life.

An Unusual Urological Manifestation of Williams-Beuren Syndrome: Posterior Urethral Valve

Williams-Beuren syndrome (WBS) is a genetic, well-defined, rare, neurodevelopmental disorder characterized by intellectual disability, congenital heart defects, abnormal facial features, and growth, endocrine, and genitourinary abnormalities. The genitourinary abnormalities in WBS frequently include congenital structural renal defects, vesicoureteral reflux, nephrocalcinosis, proteinuria, and chronic renal insufficiency. Treatment of patients with posterior urethral valve (PUV) remains a clinical challenge, requiring long-term management from early infancy into adulthood in order to avoid progressive renal insufficiency. To my knowledge, this is the first worldwide case of WBS with PUV in a 12-year-old boy. Due to the delayed detection of the defect, chronic renal disease occurred as a risk for him. This case demonstrates the importance of early diagnosis of genitourinary anomalies such as PUV to prevent chronic renal disease in boys and especially in patients with WBS.

Elastin-driven genetic diseases

Elastic fibers provide recoil to tissues that undergo repeated deformation, such as blood vessels, lungs and skin. Composed of elastin and its accessory proteins, the fibers are produced within a restricted developmental window and are stable for decades. Their eventual breakdown is associated with a loss of tissue resiliency and aging. Rare alteration of the elastin (ELN) gene produces disease by impacting protein dosage (supravalvar aortic stenosis, Williams Beuren syndrome and Williams Beuren region duplication syndrome) and protein function (autosomal dominant cutis laxa). This review highlights aspects of the elastin molecule and its assembly process that contribute to human disease and also discusses potential therapies aimed at treating diseases of elastin insufficiency.

High-resolution single nucleotide polymorphism arrays identified an atypical microdeletion of the Williams-Beuren syndrome interval in a patient presenting with a different phenotype

The present study aimed to identify the mutation causing an atypical syndrome. High-resolution single nucleotide polymorphism (SNP) arrays are considered to be a major detection method for submicroscopic chromosomal rearrangements smaller than 5 Mb in size. Genomic DNA samples of the patient and his parents were converted to a final concentration of 50 ng/ml. The Illumina BeadScan genotyping system and the HumanOmni1‑Quad Chip were employed to obtain the signal intensities of SNP probes. The patient presented with congenital heart disease, autism, mental retardation, growth retardation, hypercalcemia, nephroliths and cleft palate. The karyotypes of the patient and his parents were normal. The present study employed high‑resolution SNP arrays to analyze the whole genome for copy number variations (CNVs). A total of 309 CNVs were discovered. A de novo 1.5 Mb gain of chromosome 7q11.23 (Chr7: 72,357,322‑73,856,472) was identified following exclusion of CNVs presented in the Database of Genomic Variants. In conclusion, to the best of our knowledge, the current study describes the first case of a patient presenting with Williams‑Beuren syndrome alongside supravalvular aortic stenosis, autism and cleft palate, and identifies an atypical deletion at 7q11.23.